These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 6462114

  • 1. Endocrine complications of topical and intralesional corticosteroid therapy.
    Curtis JA, Cormode E, Laski B, Toole J, Howard N.
    Arch Dis Child; 1982 Mar; 57(3):204-7. PubMed ID: 6462114
    [Abstract] [Full Text] [Related]

  • 2. Cushing's Syndrome in a 6-month-old Boy: A Rare Side-effect due to Inadequate use of Topical Corticosteroids.
    Ciccone S, Marini R, Bizzarri C, El Hachem M, Cappa M.
    Acta Derm Venereol; 2016 Jan; 96(1):138-9. PubMed ID: 26038976
    [No Abstract] [Full Text] [Related]

  • 3. Hypothalamo-pituitary-adrenal axis in iatrogenic Cushing's syndrome.
    Tsan KW, Kuo CY.
    Taiwan Yi Xue Hui Za Zhi; 1985 Aug; 84(8):936-43. PubMed ID: 3001216
    [No Abstract] [Full Text] [Related]

  • 4. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B, Bussières JF, Tremblay S.
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [Abstract] [Full Text] [Related]

  • 5. Topical steroids and hypothalamo-pituitary-adrenal suppression: a review.
    Bartley PC.
    Australas J Dermatol; 1978 Dec; 19(3):109-13. PubMed ID: 371599
    [No Abstract] [Full Text] [Related]

  • 6. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse?
    Güven A, Gülümser O, Ozgen T.
    J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788
    [Abstract] [Full Text] [Related]

  • 7. Alcohol-induced pseudo-Cushing's syndrome.
    Jeffcoate W.
    Lancet; 1993 Mar 13; 341(8846):676-7. PubMed ID: 8095582
    [No Abstract] [Full Text] [Related]

  • 8. Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused.
    Haeck IM, Timmer-de Mik L, Lentjes EG, Buskens E, Hijnen DJ, Guikers C, Bruijnzeel-Koomen CA, de Bruin-Weller MS.
    Br J Dermatol; 2007 May 13; 156(5):979-85. PubMed ID: 17298484
    [Abstract] [Full Text] [Related]

  • 9. Topical corticosteroids in plaque psoriasis: a systematic review of risk of adrenal axis suppression and skin atrophy.
    Castela E, Archier E, Devaux S, Gallini A, Aractingi S, Cribier B, Jullien D, Aubin F, Bachelez H, Joly P, Le Maître M, Misery L, Richard MA, Paul C, Ortonne JP.
    J Eur Acad Dermatol Venereol; 2012 May 13; 26 Suppl 3():47-51. PubMed ID: 22512680
    [Abstract] [Full Text] [Related]

  • 10. Complications of corticosteroid and immunosuppressive drugs.
    Rubin B, Palestine AG.
    Int Ophthalmol Clin; 1989 May 13; 29(3):159-71. PubMed ID: 2526794
    [No Abstract] [Full Text] [Related]

  • 11. Oral corticosteroids for asthma exacerbations might be associated with adrenal suppression: Are physicians aware of that?
    Barra CB, Fontes MJF, Cintra MTG, Cruz RC, Rocha JAG, Guimarães MCC, Silva IN.
    Rev Assoc Med Bras (1992); 2017 Oct 13; 63(10):899-903. PubMed ID: 29267492
    [Abstract] [Full Text] [Related]

  • 12. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
    O'Sullivan MM, Rumfeld WR, Jones MK, Williams BD.
    Ann Rheum Dis; 1985 Aug 13; 44(8):561-3. PubMed ID: 4026419
    [Abstract] [Full Text] [Related]

  • 13. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.
    Tempark T, Phatarakijnirund V, Chatproedprai S, Watcharasindhu S, Supornsilchai V, Wananukul S.
    Endocrine; 2010 Dec 13; 38(3):328-34. PubMed ID: 20972726
    [Abstract] [Full Text] [Related]

  • 14. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC, Nieman LK, Oldfield EH, Loughlin T, Barnes KM, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1989 May 13; 68(5):912-6. PubMed ID: 2541160
    [Abstract] [Full Text] [Related]

  • 15. [Topical corticosteroid therapy in Cushing's syndrome].
    Haim S, Zamir B, Dickstein G, Barzilai D.
    Harefuah; 1981 Nov 01; 101(9):216. PubMed ID: 7347301
    [No Abstract] [Full Text] [Related]

  • 16. Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children.
    Zöllner EW, Lombard CJ, Galal U, Hough FS, Irusen EM, Weinberg E.
    Pediatrics; 2012 Dec 01; 130(6):e1512-9. PubMed ID: 23147980
    [Abstract] [Full Text] [Related]

  • 17. Inhaled corticosteroids: clinical relevance of safety measures.
    Price JF.
    Pediatr Pulmonol Suppl; 1997 Sep 01; 15():40-5. PubMed ID: 9316101
    [Abstract] [Full Text] [Related]

  • 18. Overview of the side effects of corticosteroid therapy.
    Ansell BM.
    Clin Exp Rheumatol; 1991 Sep 01; 9 Suppl 6():19-20. PubMed ID: 2060172
    [No Abstract] [Full Text] [Related]

  • 19. [Corticosteroid therapy].
    Reinhart WH.
    Praxis (Bern 1994); 2005 Feb 16; 94(7):239-43. PubMed ID: 15773140
    [Abstract] [Full Text] [Related]

  • 20. Cushing's syndrome: hidden risk in usage of topical corticosteroids.
    Buluş AD, Andıran N, Koçak M.
    J Pediatr Endocrinol Metab; 2014 Sep 16; 27(9-10):977-81. PubMed ID: 24854522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.